Literature DB >> 9784154

Ursolic acid from Plantago major, a selective inhibitor of cyclooxygenase-2 catalyzed prostaglandin biosynthesis.

T Ringbom1, L Segura, Y Noreen, P Perera, L Bohlin.   

Abstract

A hexane extract of Plantago major was investigated by bioactivity-directed fractionation, using an in vitro cyclooxygenase-2 (COX-2) catalyzed prostaglandin biosynthesis inhibition assay, and resulted in the isolation of ursolic acid (1). This triterpenoid showed a significant COX-2 inhibitory effect, directly on the enzyme activity, with an IC50 value of 130 microM and a COX-2/COX-1 selectivity ratio of 0.6. The structural isomer oleanolic acid (2) was found to be less active than 1, with an IC50 value of 295 microM, but showed a similar selectivity ratio (0.8). Furthermore, no significant inhibition on COX-2 or COX-1 was observed by the triterpenoid, 18beta-glycyrrhetinic acid (3). The direct inhibitory effect of 1 and 2 on COX-2 catalyzed prostaglandin biosynthesis increased with preincubation, indicating a time-dependent inhibition, while the effect on COX-1 was found to be independent of preincubation time.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784154     DOI: 10.1021/np980088i

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  19 in total

Review 1.  Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae).

Authors:  Anita M Brinker; Jun Ma; Peter E Lipsky; Ilya Raskin
Journal:  Phytochemistry       Date:  2007-01-23       Impact factor: 4.072

2.  Role of ursolic acid chalcone, a synthetic analogue of ursolic acid, in inhibiting the properties of CD133(+) sphere-forming cells in liver stem cells.

Authors:  Rui-Xin Lin; Lu-Lu Gong; Li-Mei Fan; Zhong-Kai Zhao; Shu-Li Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  Hepatoprotective and anti-inflammatory activities of Plantago major L.

Authors:  Idris Türel; Hanefi Ozbek; Remzi Erten; Ahmet Cihat Oner; Nureddin Cengiz; Orhan Yilmaz
Journal:  Indian J Pharmacol       Date:  2009-06       Impact factor: 1.200

4.  Anti-inflammatory and analgesic components from "hierba santa," a traditional medicine in Peru.

Authors:  Marii Kawano; Mayumi Otsuka; Kazuhiro Umeyama; Mikio Yamazaki; Tetsuo Shiota; Motoyoshi Satake; Emi Okuyama
Journal:  J Nat Med       Date:  2008-12-06       Impact factor: 2.343

5.  Anti-herpes virus activities of bioactive fraction and isolated pure constituent of Mallotus peltatus: an ethnomedicine from Andaman Islands.

Authors:  Paromita Bag; Debprasad Chattopadhyay; Hemanta Mukherjee; Durbadal Ojha; Nilanjan Mandal; Mamta Chawla Sarkar; Tapan Chatterjee; Gobardhan Das; Sekhar Chakraborti
Journal:  Virol J       Date:  2012-05-24       Impact factor: 4.099

6.  A rapid screening method for detecting active compounds against erythromycin-resistant bacterial strains of Finnish origin.

Authors:  K Kreander; P Vuorela; P Tammela
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.629

7.  3-Oxo-18α-olean-28,13β-olide.

Authors:  R C Santos; R M A Pinto; A Matos Beja; J A R Salvador; J A Paixão
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-31

8.  Potent anti-inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF-κB, AP-1 and NF-AT.

Authors:  Rahul Checker; Santosh K Sandur; Deepak Sharma; Raghavendra S Patwardhan; S Jayakumar; Vineet Kohli; Gautam Sethi; Bharat B Aggarwal; Krishna B Sainis
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

9.  Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats.

Authors:  David Andersson; Yajun Cheng; Rui-Dong Duan
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-29       Impact factor: 4.322

10.  Non-experimental validation of ethnoveterinary plants and indigenous knowledge used for backyard pigs and chickens in Trinidad and Tobago.

Authors:  C Lans; K Georges; G Brown
Journal:  Trop Anim Health Prod       Date:  2007-06       Impact factor: 1.893

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.